Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Congest Heart Fail. 2012 Jul 2;18(6):315–319. doi: 10.1111/j.1751-7133.2012.00303.x

TABLE II.

Biochemical and Echocardiographic Characteristicsa (N=13)

Baseline Follow-Up P Value
Biochemical
 Hemoglobin, g/dL 13.7±0.3 14.0±0.4 .55
 Platelets, 109/L 179±12 168±11 .81
 BUN, mg/dL 22±2 27±3 .44
 Creatinine, mg/dL 1.2±0.1 1.2±0.1 .74
 eGFR, mL/min 82±8 77±8 .35
 Troponin I, ng/mL 0.04±0.01 0.07±0.02 .08
 BNP, pg/mL 388±92 481±102 .52
 Albumin, g/dL 4.1±0.1 4.0±0.1 .33
 Modified BMI, kg g/m2 dL 100±4 95±4 .21
Echocardiographic
 LV ejection fraction, % 50±3 48±6 .61
 LV end-diastolic diameter, cm 4.4±0.1 4.5±0.1 .33
 Interventricular septal thickness, cm 1.8±0.1 1.6±0.1 .25
 LV posterior wall thickness, cm 1.6±0.1 1.5±0.2 .50
 LA diameter, cm 4.6±0.2 4.5±0.2 .80
 LV mass, g/m2 384±37 331±65 .36

Abbreviations: BMI, body mass index; BNP, B-type natriuretic peptide; BUN, serum urea nitrogen; eGFR, estimated glomerular filtration rate; LA, left atrial; LV, left ventricular.

a

Mean±standard error at baseline and follow-up, change, and P value from Kruskal-Wallis test are shown.